CPHA Canvax
Abstract

The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2020/2021 influenza season are not substantially changed from those of last season except for permitting the use of live attenuated influenza vaccine in selected children with well-controlled HIV infection. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. LAIV will again be available in Canada for the 2020/2021 season. NACI has also addressed issues related to provision of influenza vaccine during the COVID-19 pandemic.


Web link

Vaccine recommendations for children and youth for the 2020/2021 influenza season

Related Resources

Bookmark

Implementation Tool

Link

Category

Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Preventable Diseases,Communicable Diseases,Influenza Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Influenza

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.